CNS, oncology and HIV clinical trials: Current trends and future prospects

Phil Collis, Gordon McVie

Research output: Contribution to journalArticle

Abstract

Canvas opinion around the medical and scientific communities as to the therapeutic areas presenting the greatest challenges for the pharmaceutical industry in the 21st Century, and the chances are the CNS disease (a term covering a broad spectrum of pathologies), oncology and HIV infection will be at the top of many people's lists. Whilst some significant advances have occurred in these therapeutic areas over the last decade, the continuing morbidity and mortality associated with a diagnosis in these areas confirms the need for new therapies.

Original languageEnglish
Pages (from-to)102-106
Number of pages5
JournalEuropean Pharmaceutical Contractor
Issue numberSPRING
Publication statusPublished - Mar 2004

    Fingerprint

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this